Health Canada drug identification number

DIN 02417235 — KAZANO 1000 MG; 12.5 MG

KAZANO is a tablet of Alogliptin / Metformin marketed by TAKEDA CANADA INC. The full Alogliptin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02417235
Brand name
KAZANO
Active ingredient
Alogliptin / Metformin
Strength
1000 MG; 12.5 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
TAKEDA CANADA INC
Health Canada status
MARKETED
Drug class
Combination oral antidiabetic (DPP-4 inhibitor + biguanide)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Alogliptin / Metformin products

DINBrandStrengthFormManufacturerStatus
02417227 KAZANO 12.5 MG; 850 MG TABLET TAKEDA CANADA INC MARKETED
02417219 KAZANO 500 MG; 12.5 MG TABLET TAKEDA CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.